Article Sidebar

PDF
Date Published: 17/02/2023
Abstract Views: 199
Views PDF: 129
DOI: https://doi.org/10.51298/vmj.v520i2.4188
Issue
Vol. 520 No. 2 (2022)
Section
Các bài báo
How to Cite
Tô, N. T., Phạm, T. N. T., & Lê, M. K. (2023). INCIDENCE, CHARACTERISTICS, RISK FACTORS AND EFFECTS OF ACUTE KIDNEY INJURY IN SEVERE AND CRITICAL COVID-19 PATIENTS. Vietnam Medical Journal, 520(2). https://doi.org/10.51298/vmj.v520i2.4188

INCIDENCE, CHARACTERISTICS, RISK FACTORS AND EFFECTS OF ACUTE KIDNEY INJURY IN SEVERE AND CRITICAL COVID-19 PATIENTS

Nhuận Thủ Tô1, Thị Ngọc Thảo Phạm2, Minh Khôi Lê2,3,
1 Xuyen A hospital
2 University of Medicine and Pharmacy at Ho Chi Minh City
3 University of Medicine and Pharmacy at Ho Chi Minh City hospital

Main Article Content

Abstract

Objective: This study aimed to describe the characteristics and to determine the incidence, risk factors and effects of acute kidney injury (AKI) in severe and critical COVID-19 patients. Method: We retrospectively studied COVID-19 patients admitted to the COVID-19 Intensive Care Center, University Medical Center Ho Chi Minh City. Results: The study recruited 356 severe and critical COVID-19 patients. The AKI incidence was 59.8%, among which stage 2 of 13.8% and stage 3 of 23.6%. Cytokine score and colistin use were independently related to the occurrence of AKI. The median time of hospital stay was of 15 days. 14.6%, 50.3%, and 17.42% of patients required renal replacement therapy, invasive mechanical ventilation, and blood transfusion, respectively. The overall mortality was 35.96%. The patients with AKI had a longer hospital stay, higher rate of invasive mechanical ventilation, blood transfusion, and mortality. Conclusions: AKI was common in severe and critical COVID-19 patients and associated with increased disease severity, prolonged hospital stay and higher mortality.

Article Details

Keywords

COVID-19, acute kidney injury, renal replacement therapy, mortality

References

1. Bộ Y tế. Hướng dẫn chẩn đoán và điều trị COVID-19 do chủng virus Corona mới (SAR-CoV-2). 2021.
2. Phan Thị Xuân. Tỉ lệ tổn thương thận cấp và các yếu tố nguy cơ tổn thương ở bệnh nhân hồi sức sử dụng Colistin đường tĩnh mạch. Y học TP. Hồ Chí Minh. 2015;19(1):297-302.
3. Koyner JL, Topf J, Lerma E. Handbook of Critical Care Nephrology. 1st ed. Lippincott Williams & Wilkins; 2021:I4, II5-6.
4. Chen YT, Shao SC, Hsu CK, et al. Incidence of acute kidney injury in COVID-19 infection: a systematic review and meta-analysis. Critical Care. 2020;24(1):1-4.
5. Nadim MK, Forni LG, Mehta RL, et al. COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup. Nature reviews nephrology. 2020;16(12):747-764.
6. Ng JH, Hirsch JS, Hazzan A, et al. Outcomes among patients hospitalized with COVID-19 and acute kidney injury. American Journal of Kidney Diseases. 2021;77(2):204-215.
7. Srisawat N, Sileanu FE, Murugan R, et al. Variation in Risk and Mortality of Acute Kidney Injury in Critically Ill Patients: A Multicenter Study. American Journal of Nephrology. 2015;41(1):81-88.
8. Thakkar J, Chand S, Aboodi MS, et al. Characteristics, Outcomes and 60-Day Hospital Mortality of ICU Patients with COVID-19 and Acute Kidney Injury. Kidney360. 2020; 1(12):1339-1344.